Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1
- Reck, M.
- Ciuleanu, T.-E.
- Lee, J.-S.
- Schenker, M.
- Zurawski, B.
- Kim, S.-W.
- Mahave, M.
- Alexandru, A.
- Peters, S.
- Pluzanski, A.
- Caro, R.B.
- Linardou, H.
- Burgers, J.A.
- Nishio, M.
- Martinez-Marti, A.
- Azuma, K.
- Axelrod, R.
- Paz-Ares, L.G.
- Ramalingam, S.S.
- Borghaei, H.
- O'Byrne, K.J.
- Li, L.
- Bushong, J.
- Gupta, R.G.
- Grootendorst, D.J.
- Eccles, L.J.
- Brahmer, J.R.
- Erakutsi egile guztiak +
ISSN: 1556-1380, 1556-0864
Argitalpen urtea: 2023
Alea: 18
Zenbakia: 8
Orrialdeak: 1055-1069
Mota: Artikulua